Trial record 1 of 1 for:    ict-107
Previous Study | Return to List | Next Study

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
ImmunoCellular Therapeutics, Ltd.
ClinicalTrials.gov Identifier:
NCT01280552
First received: January 19, 2011
Last updated: October 17, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)